These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


452 related items for PubMed ID: 2436387

  • 21. Evaluation of the human interferon system in viral disease.
    Levin S, Hahn T.
    Clin Exp Immunol; 1981 Dec; 46(3):475-83. PubMed ID: 6175461
    [Abstract] [Full Text] [Related]

  • 22. [Interferon--a new therapeutic principle].
    Micksche M.
    Wien Med Wochenschr; 1993 Dec; 143(16-17):408-12. PubMed ID: 8273362
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
    Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S.
    Cancer Res; 1998 Jun 15; 58(12):2489-99. PubMed ID: 9635566
    [Abstract] [Full Text] [Related]

  • 26. [Update on the use of interferons in clinical practice].
    Lauta VM.
    Clin Ter; 1995 Jun 15; 146(6-7):393-448. PubMed ID: 7586995
    [Abstract] [Full Text] [Related]

  • 27. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M.
    Arch Immunol Ther Exp (Warsz); 1987 Jun 15; 35(4):489-99. PubMed ID: 2449874
    [Abstract] [Full Text] [Related]

  • 28. [Human interferons -- features and chances (author's transl)].
    Pohl A, Moser K, Micksche M.
    Wien Klin Wochenschr; 1981 Jul 10; 93(14):439-57. PubMed ID: 6168122
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL.
    Immunol Rev; 2008 Dec 10; 226():29-40. PubMed ID: 19161414
    [Abstract] [Full Text] [Related]

  • 33. [Physiological interferons and their role in the body. I. Biological activities of interferons].
    Błach-Olszewska Z.
    Postepy Hig Med Dosw; 1988 Dec 10; 42(3):260-95. PubMed ID: 3150039
    [No Abstract] [Full Text] [Related]

  • 34. Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
    Sulica A, Gherman M, Manciulea M, Galatiuc C, Herberman RB.
    Nat Immun Cell Growth Regul; 1989 Dec 10; 8(5):266-78. PubMed ID: 2480519
    [Abstract] [Full Text] [Related]

  • 35. The antiviral activity of tumor necrosis factor in HeLa cells is not mediated by interferons. Studies with TNF-resistant variants.
    Gessani S, Johnson SE, McCandless S, Baglioni C.
    J Biol Regul Homeost Agents; 1988 Dec 10; 2(3):139-44. PubMed ID: 2474237
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Interferons in hemato-cancerology].
    Boiron M.
    Nouv Rev Fr Hematol (1978); 1987 Dec 10; 29(1):49-55. PubMed ID: 2438645
    [Abstract] [Full Text] [Related]

  • 38. Interferon as therapeutic agent.
    Borecký L, Fuchsberger N.
    Acta Virol; 1983 Jul 10; 27(4):359-70. PubMed ID: 6195902
    [Abstract] [Full Text] [Related]

  • 39. Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferon.
    Hubbell HR, Craft JA, Leibowitz PJ, Gillespie DH.
    J Biol Response Mod; 1987 Apr 10; 6(2):141-53. PubMed ID: 3108460
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.